(Q35880956)

10 August 2017

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast (English)

1 reference

10 August 2017

1 reference

Bert van der Vegt

2

0 references

Geertruida H de Bock

object named as

Geertruida H de Bock

5

0 references

author name string

Marnix A de Roos

1

1 reference

10 August 2017

Jaap de Vries

3

1 reference

10 August 2017

Jelle Wesseling

4

1 reference

10 August 2017

24 April 2007

1 reference

Annals of Surgical Oncology

10 August 2017

1 reference

10 August 2017

14

1 reference

10 August 2017

7

1 reference

10 August 2017

2097-2104

1 reference

Correlation between imaging and pathology in ductal carcinoma in situ of the breast

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Detection of ductal carcinoma in situ in women undergoing screening mammography

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Molecular markers and therapeutic targets in ductal carcinoma in situ

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Consequences of breast screening.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Tissue microarrays for high-throughput molecular profiling of tumor specimens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Trends of in situ carcinoma of the breast in Vaud, Switzerland

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Ductal carcinoma in situ: a proposal for a new classification

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1245%2FS10434-007-9395-7

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Histopathological and cell biological factors of ductal carcinoma in situ before and after the introduction of mammographic screening

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Trends in incidence and treatment of ductal carcinoma in situ of the breast in southeast Netherlands

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Incidence of and treatment for ductal carcinoma in situ of the breast.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

Mammographically detected ductal carcinoma in situ: Are we overdiagnosing breast cancer?d

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1914276

In microdissected ductal carcinoma in situ, HER-2/neu amplification, but notp53 mutation, is associated with high nuclear grade and comedo histology

24 September 2018

1 reference

12 December 2020

Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast

1 reference

12 December 2020

Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype

1 reference

12 December 2020

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

12 December 2020

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

1 reference

12 December 2020

Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation

1 reference

12 December 2020

Comparison of pathological and biological features of symptomatic and mammographically detected ductal carcinoma in situ of the breast

1 reference

12 December 2020

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

12 December 2020

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

12 December 2020

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

12 December 2020

Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

1 reference

12 December 2020

Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?

1 reference

12 December 2020

How significant is detection of ductal carcinoma in situ in a breast screening programme?

1 reference

12 December 2020

10.1245/S10434-007-9395-7

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

17453296

1 reference